Supplementary information
=========================

 {#Sec1}

**Additional file 1.** Full Study Protocol.

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information
=========================

**Supplementary information** accompanies this paper at 10.1186/s13063-020-04488-8.

Not applicable.

JPD, CG, CLC and JP conceived the study, coordinated its design, drafted and wrote the manuscript. JPD, CG, CLC, JL, OM, MRL, FL, SLT, MC, NE, PT and JP read and were involved in critical appraisal and revision of the manuscript. CLC and JL provided statistical expertise. All authors approved the final manuscript prior to submission.

Aerogen (Ireland) will provide nebulizers to the study centers. Roche (Switzerland) will provide dornase alfa to the study centers.

Funders will have no role in the study's design, collection, management, analysis and interpretation of data, writing of the report and the decision to submit the report for publication conception or in the data analysis.

Study documents will be de-identified, stored in each recruitment centre and kept for at least 15 years in a locked, secure office, according to French law. All personnel involved in data analysis will be masked. Only the principal investigators, the DSMB and the statisticians will have access to the final data set. The data sets used and analysed during the current study will be available from the corresponding author on reasonable request, after publication of the main core article.

The Comité de Protection des Personnes Ouest IV-Nantes approved the study on April 4^th^, 2020 (Reference: CPP 39/20_1, file number 20.4.01.46248). We therefore certify that the COVIDornase trial has received ethical approval from the appropriate ethical committee.

Inclusion will be feasible after patient approval, next of kin approval or emergency consent procedure (according to French law). Subsequent confirmation of consent will be obtained from the relatives and from the patient as soon as possible.
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